Skip to main content
OpenTrials

Clinical trial condition

B-cell Chronic Lymphocytic Leukemia

Explore clinical trials studying B-cell Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

44 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

B-cell Chronic Lymphocytic Leukemia trial results

Completed

Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)

NCT01292135

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations
  • Dana Farber Cancer Center Boston, Massachusetts, United States
  • CLL Research and Treatment Program New Hyde Park, New York, United States
  • Weill Medical College of Cornell University New York, United States
  • University of Rochester Rochester, New York, United States
View Trial Details
Completed

CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00290472

Conditions
B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Burkitt Lymphoma, +54 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
  • Evanston Hospital CCOP Evanston, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View all 13 locations
View Trial Details
Completed

Safety of PCI-32765 in Chronic Lymphocytic Leukemia

NCT01105247

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • New York Presbyterian Hosptial Cornell Med Center New York, United States
  • The Ohio State University Columbus, Ohio, United States
  • Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States
View Trial Details
Completed

Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients

NCT00086580

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Medizinische Universitatsklinik Graz Graz, Austria
  • Universitat Wien AKH, Innere Medizin I Vienna, Austria
  • University Multiprofile Hospital for Active Treatment Dr. Georgi Stranski Pleven, Bulgaria
View all 48 locations
View Trial Details

Related conditions